Human leukemic cells loaded with alpha-galactosylceramide (alpha-GalCer) activate murine NKT cells in situ (Q39863367)

15 September 2017

title

Human leukemic cells loaded with alpha-galactosylceramide (alpha-GalCer) activate murine NKT cells in situ (English)

1 reference

15 September 2017

1 reference

Kanako Shimizu

1

1 reference

15 September 2017

Michihiro Hidaka

2

1 reference

15 September 2017

Kara Bickham

3

1 reference

15 September 2017

Mina Moriwaki

4

1 reference

15 September 2017

Koji Fujimoto

5

1 reference

15 September 2017

Fumio Kawano

6

1 reference

15 September 2017

Shin-ichiro Fujii

7

1 reference

15 September 2017

language of work or name

1 reference

16 June 2010

1 reference

International Journal of Hematology

15 September 2017

published in

1 reference

15 September 2017

volume

92

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

152-160

1 reference

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0616-7

Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0616-7

T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0616-7

Direct antigen presentation by a xenograft induces immunity independently of secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0616-7

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes

21 January 2018

1 reference

12 December 2020

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients

1 reference

12 December 2020

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells

1 reference

12 December 2020

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

12 December 2020

Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients

1 reference

12 December 2020

A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer

1 reference

12 December 2020

Tumor-host immune interactions and dendritic cell dysfunction

1 reference

12 December 2020

Toward an understanding of NKT cell biology: progress and paradoxes

1 reference

12 December 2020

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

1 reference

12 December 2020

Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide

1 reference

12 December 2020

Recognition of bacterial glycosphingolipids by natural killer T cells

1 reference

12 December 2020

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

1 reference

12 December 2020

Evaluation of the function of human invariant NKT cells from cancer patients using alpha-galactosylceramide-loaded murine dendritic cells

1 reference

12 December 2020

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

1 reference

12 December 2020

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

1 reference

12 December 2020

CD1: antigen presentation and T cell function

1 reference

12 December 2020

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

1 reference

12 December 2020

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

1 reference

12 December 2020

Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies

1 reference

12 December 2020

Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer

1 reference

12 December 2020

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

1 reference

12 December 2020

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

12 December 2020

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity

1 reference

12 December 2020

Application of natural killer T-cells to posttransplantation immunotherapy

1 reference

12 December 2020

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells

1 reference

12 December 2020

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

12 December 2020

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

12 December 2020

Highly conserved antigen-presenting function of CD1d molecules

1 reference

12 December 2020

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

12 December 2020

The biology of NKT cells

1 reference

12 December 2020

Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells

1 reference

12 December 2020

Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer

1 reference

12 December 2020

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

12 December 2020

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells

1 reference

12 December 2020

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice

1 reference

12 December 2020

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

12 December 2020

CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.

1 reference

12 December 2020

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

12 December 2020

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

1 reference

12 December 2020

10.1007/S12185-010-0616-7

Identifiers

DOI

1 reference

15 September 2017

1 reference